Instituto De Retina Genomica

17/03/2026

12/02/2026

02/02/2026

https://www.facebook.com/share/p/1CNq91zquA/

De novo and inherited dominant variants in genes encoding U4 and U6 small nuclear RNAs are identified in individuals with retinitis pigmentosa. The variants cluster at nucleotide positions distinct from those implicated in neurodevelopmental disorders.

09/01/2026

https://www.facebook.com/share/1VrXeSFvvW/?mibextid=wwXIfr

02/12/2025

Primer paciente distrofia de retina BEST1, en tratamiento génico.

Emerging gene therapy administered through a one-time subretinal injection marks a major milestone for the inherited retinal disease community…...

26/11/2025

Avanzando en Stargardts

03/11/2025

Retinosis pigmentaria cura, otro gene modificador para varios genes ( gene-agnóstico). https://sparingvision.com/sparingvision-doses-first-patient-with-spvn20-for-advanced-retinitis-pigmentosa-in-nyrvana-trial/🥳

Favorable safety profile of SPVN06 observed in Phase I including nine patients with severe advanced retinitis pigmentosa. Trial advances into Phase II extension phase, with two highest doses of SPVN06, following DSMB positive recommendation

03/11/2025

Avanzando en Stargardts. ¡ Contáctenos !

02/11/2025

Retinosis pigmentaria cura - otro promotor para varios genes. ¡ Contáctenos !

29/10/2025

Mejoran 15 líneas pacientes con Retinosis, Stargardts y degeneración macular.

Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology....

20/10/2025

Microchip instalado en pacientes con Degeneacion mácula. Recobran visión.

The results are astounding and a major advance, say surgeons involved in international research using the pioneering technology.

03/10/2025

Paciente con distrofia de retina tipo Stargardt´s ABCA4 rumbo al tratamiento. 🥳